We have reported that IgM anti-PC is a protection marker for several chronic inflammatory disease conditions, including atherosclerosis and cardiovascular disease (CVD), rheumatic diseases, especially systemic lupus erythematosus (SLE), and mortality in chronic kidney disease (1–5). This evidence concerns the gene CD40LG and systemic lupus erythematosus.